Astria Therapeutics
ATXS
ATXS
65 hedge funds and large institutions have $312M invested in Astria Therapeutics in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 28 increasing their positions, 11 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
4% less capital invested
Capital invested by funds: $326M → $312M (-$14.2M)
46.87% less ownership
Funds ownership: 130.51% → 83.64% (-47%)
Holders
65
Holding in Top 10
4
Calls
$316K
Puts
$118K
Top Buyers
| 1 | +$8.81M | |
| 2 | +$6.46M | |
| 3 | +$2.62M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$2.58M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
+$2.39M |
Top Sellers
| 1 | -$8.64M | |
| 2 | -$5.01M | |
| 3 | -$3.35M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.79M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.6M |